Mediaspace scheduled maintenance: Aug 25, 2026 07:00 - 12:00 AM. During this time, videos will be temporarily unavailable. Check status updates.

Home

Person

Ghyslain Martial Alain Budin

This person has left EPFL

About
Privacy
Disclaimer

Graph Chatbot

Related publications (4)

Page 1 of 1

A bioluminescent probe for longitudinal monitoring of mitochondrial membrane potential

Elena Goun, Riccardo Sinisi, Arkadiy Bazhin, Tamara Maric, Ghyslain Martial Alain Budin

Mitochondrial membrane potential (Delta Psi(m)) is a universal selective indicator of mitochondrial function and is known to play a central role in many human pathologies, such as diabetes mellitus, cancer and Alzheimer's and Parkinson's diseases. Here, we ...

NATURE RESEARCH2020

Preclinical Evaluation of Photoacoustic Imaging as a Novel Noninvasive Approach to Detect an Orthopaedic Implant Infection

Riccardo Sinisi, Pavlo Khodakivskyi, Ghyslain Martial Alain Budin

Introduction: Diagnosing-prosthetic joint infection (PJI) poses significant challenges, and current modalities are fraught with low sensitivity and/or potential morbidity. Photoacoustic imaging (PAI) is a novel ultrasound-based modality with potential for ...

Lippincott Williams & Wilkins2017

Bioluminescence imaging of small biomolecules

Elena Goun, Aurélien Godinat, Riccardo Sinisi, Grigory Karateev, Ghyslain Martial Alain Budin, Aleksandra Konovalova, Jens Tomas Frigell

The invention relates to a technique to detect small molecules using Bioluminescence imaging (BLI) to image and quantify non-invasively, in vitro and in vivo,intracellular metabolite fluxes and which can be applied to azido-modified compounds, such as azid ...

2014

Portable bioluminescent platform for in vivo monitoring of biological processes in non-transgenic animals

Elena Goun, Aurélien Godinat, Arkadiy Bazhin, Pavlo Khodakivskyi, Tamara Maric, Aleksey Yevtodiyenko, Ghyslain Martial Alain Budin

Bioluminescent imaging (BLI) is one of the most powerful and widely used preclinical imaging modalities. However, the current technology relies on the use of transgenic luciferase-expressing cells and animals and therefore can only be applied to a limited ...

Nature Research2021